The effect of orlistat and metformin in the treatment of fatty liver disease
Phase 2
- Conditions
- Fatty liver.nonalcoholic steatohepatitis(K75.8)
- Registration Number
- IRCT2016031827097N1
- Lead Sponsor
- Ardebil University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
( Having Nonalcoholic fatty liver disease, the absence of diabetes mellitus, Fatty liver grade 2 and above, not having severe systemic disease, Lack of viral and autoimmune hepatitis, Lack of thyroid disease, do not have hyper triglyceridemia and Exclusion criteria: Having severe systemic disease, having viral hepatitis and autoimmune, having thyroid disease, Hyper triglyceridemia)
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Triglyceride of blood. Timepoint: Befor and after the study. Method of measurement: Milligrams per deciliter.
- Secondary Outcome Measures
Name Time Method